These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23922354)

  • 1. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine.
    Bouillon R; Van Schoor NM; Gielen E; Boonen S; Mathieu C; Vanderschueren D; Lips P
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1283-304. PubMed ID: 23922354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
    Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
    Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Parathyroid Hormone Responses to Vitamin D Supplementation in Overweight/Obese Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Lotito A; Teramoto M; Cheung M; Becker K; Sukumar D
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28272298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
    Wamberg L; Pedersen SB; Richelsen B; Rejnmark L
    Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people.
    Sayed-Hassan R; Abazid N; Alourfi Z
    Arch Osteoporos; 2014; 9():176. PubMed ID: 24715441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vitamin D status on vertebral fractures, bone mineral density, and bone turnover markers in normocalcemic postmenopausal women with high parathyroid hormone levels.
    Hernández JL; Olmos JM; Pariente E; Nan D; Martínez J; Llorca J; Valero C; Obregón E; González-Macías J
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1711-7. PubMed ID: 23457409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations.
    van Atteveld JE; Verhagen IE; van den Heuvel-Eibrink MM; van Santen HM; van der Sluis IM; Di Iorgi N; Simmons JH; Ward LM; Neggers SJCMM
    Cancer Med; 2021 Jul; 10(13):4177-4194. PubMed ID: 34100559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study.
    Welsh P; Doolin O; McConnachie A; Boulton E; McNeil G; Macdonald H; Hardcastle A; Hart C; Upton M; Watt G; Sattar N
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4578-87. PubMed ID: 23071162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? a placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D3 every 3 months in elderly women.
    Välimäki VV; Löyttyniemi E; Pekkarinen T; Välimäki MJ
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):837-44. PubMed ID: 26725707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threshold Effects of Vitamin D Status on Bone Health in Chinese Adolescents With Low Calcium Intake.
    Wu F; Laslett LL; Zhang Q
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4481-9. PubMed ID: 26465394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis.
    West NE; Lechtzin N; Merlo CA; Turowski JB; Davis ME; Ramsay MZ; Watts SL; Stenner SP; Boyle MP
    Chest; 2011 Aug; 140(2):469-474. PubMed ID: 21393390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women.
    Mastaglia SR; Mautalen CA; Parisi MS; Oliveri B
    Eur J Clin Nutr; 2006 May; 60(5):681-7. PubMed ID: 16391587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Calcium and Two Doses of Vitamin D on Bone Metabolism in the Elderly: A Randomized Controlled Trial.
    Rahme M; Sharara SL; Baddoura R; Habib RH; Halaby G; Arabi A; Singh RJ; Kassem M; Mahfoud Z; Hoteit M; Daher RT; Bassil D; El Ferkh K; El-Hajj Fuleihan G
    J Bone Miner Res; 2017 Jul; 32(7):1486-1495. PubMed ID: 28276596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cavalier E; Chanson P
    Endocrine; 2016 Aug; 53(2):543-50. PubMed ID: 27106800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.
    Touvier M; Deschasaux M; Montourcy M; Sutton A; Charnaux N; Kesse-Guyot E; Fezeu LK; Latino-Martel P; Druesne-Pecollo N; Malvy D; Galan P; Hercberg S; Ezzedine K; Souberbielle JC
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1196-203. PubMed ID: 24527713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
    Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.